| (Values in U.S. Thousands) | Nov, 2024 | Nov, 2023 | Nov, 2022 | Nov, 2021 | Nov, 2020 |
| Sales | 0 | 250 | 190 | 22 | 0 |
| Sales Growth | -100.00% | +31.97% | +775.30% | unch | unch |
| Net Income | -318 | -300 | -8,521 | -8,887 | -4,381 |
| Net Income Growth | -5.97% | +96.48% | +4.12% | -102.82% | -2,885.01% |
Entheon Biomedical Corp (ENBI.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Entheon Biomedical Corp is a biotechnology research and development company committed to treat addiction and substance use disorders.
Fiscal Year End Date: 11/30